Beclomethasone Dipropionate in Participants At Least 12 Years Old With Persistent Asthma

Study Title

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Teva Identifier

BDB-AS-301 | 2013-003397-27

ClinicalTrials.gov Identifier

NCT02031640

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Beclomethasone dipropionate | Drug: Placebo | Drug: Albuterol/salbutamol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

12/01/2013 - 12/01/2014

Phase

Phase 3

Study Type

Interventional